Pluri Inc.
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
PLUR | TA
Overview
Corporate Details
- ISIN(s):
- US72942G2030
- LEI:
- Country:
- Israel
- Address:
- Park Building No. 5, 3508409 Haifa
- Website:
- https://pluri-biotech.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pluri Inc., formerly Pluristem Therapeutics, is a biotechnology company that researches, develops, and manufactures cell-based products and therapeutics. The company specializes in its proprietary 3D cell-expansion technology platform, which is used to create solutions for commercial use aimed at improving human well-being and sustainability. Pluri develops products from placenta-based cells for applications across the medical and pharmaceutical industries, often in collaboration with research partners and academic institutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-13 16:58 |
Regulatory News Service
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Eitan Ajchenbaum
|
Hebrew (modern) | 164.3 KB | ||
| 2025-11-13 16:58 |
Foreign Filer Report
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Eitan Ajchenbaum
|
English | 36.5 KB | ||
| 2025-11-13 16:04 |
Regulatory News Service
Pluri and Subsidiaries Earn Multiple Industry Honors, Named as Overall BioAgric…
|
Hebrew (modern) | 130.5 KB | ||
| 2025-11-13 16:04 |
Foreign Filer Report
Pluri and Subsidiaries Earn Multiple Industry Honors, Named as Overall BioAgric…
|
English | 36.4 KB | ||
| 2025-11-13 00:49 |
Regulatory News Service
Report of Periodic or Interim Report
|
Hebrew (modern) | 509.3 KB | ||
| 2025-11-13 00:49 |
Foreign Filer Report
Report of Periodic or Interim Report
|
English | 36.6 KB | ||
| 2025-11-11 16:01 |
Regulatory News Service
Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regener…
|
Hebrew (modern) | 144.7 KB | ||
| 2025-11-11 16:01 |
Foreign Filer Report
Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regener…
|
English | 36.4 KB | ||
| 2025-11-10 16:10 |
Regulatory News Service
Leading Global Players Back and Fund Pluri’s Cell-Based Food and Agriculture Co…
|
English | 149.9 KB | ||
| 2025-11-10 16:10 |
Foreign Filer Report
Leading Global Players Back and Fund Pluri’s Cell-Based Food and Agriculture Co…
|
English | 36.3 KB | ||
| 2025-10-17 02:42 |
Director's Dealing
Other Report or Announcement
|
English | 244.9 KB | ||
| 2025-10-17 02:42 |
Foreign Filer Report
Other Report or Announcement
|
English | 36.4 KB | ||
| 2025-10-17 02:40 |
Remuneration Information
Immediate Report
|
English | 161.6 KB | ||
| 2025-10-17 02:40 |
Foreign Filer Report
Immediate Report
|
English | 36.4 KB | ||
| 2025-10-08 18:02 |
Regulatory News Service
Pluri Subsidiary Coffeesai and Instituto del Cafe de Chiapas Announce Strategic…
|
English | 146.0 KB |
Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pluri Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pluri Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
